United States · FDA National Drug Code directory

Liothyronine sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1943_ea5f289f-acad-4c98-8e81-82f2d3ed5855
Product NDC
71335-1943
Form
TABLET
Composition / generic term
Liothyronine sodium
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20210201
Source listing expiry
20261231

Source-listed ingredients

  • LIOTHYRONINE SODIUM — 25 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-1943-1) · 71335-1943-1
  • 28 TABLET in 1 BOTTLE (71335-1943-2) · 71335-1943-2
  • 60 TABLET in 1 BOTTLE (71335-1943-3) · 71335-1943-3
  • 100 TABLET in 1 BOTTLE (71335-1943-4) · 71335-1943-4
  • 90 TABLET in 1 BOTTLE (71335-1943-5) · 71335-1943-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →